Bomfim et al. [38] observed that the anti-TLR4 antibody treatment of resistant arteries from spontaneously hypertensive rats led to a decrease in serum levels of TLR4, COX-2, and IL-6, suggesting an association between TLR4 and hypertension-related low-grade inflammation. The gene discussed is TLR4; the disease is hypertensive disorder.